Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations

doi:10.4254/wjh.v14.i4.754

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4439)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

205

WORD

HTML

2275

Figures (1-1)

324

Tables (1-4)

301

Sum=3201

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

420

Download

818

Sum=1238

Apr 27, 2022 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Apr 27, 2022; 14(4): 754-765
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.754

Open in New Tab Full Size Figure Download Figure

Figure 1 Absolute change in liver fat in all patients receiving placebo and testosterone therapy from baseline to 40 wk follow up, reported as proportion of fat. Lines connect observations from the same participant. Red indicates an increase, green a decrease in liver fat proportion.

Citation: Apostolov R, Gianatti E, Wong D, Kutaiba N, Gow P, Grossmann M, Sinclair M. Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. World J Hepatol 2022; 14(4): 754-765
URL: https://www.wjgnet.com/1948-5182/full/v14/i4/754.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i4.754